Showing 1 - 15 results of 15 for search 'Giorgio Frega', query time: 0.05s
Refine Results
-
1
-
2
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications by Giorgio Frega, Qi Wu, Julie Le Naour, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer, Oliver Kepp
Published 2020-01-01
Article -
3
-
4
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations. by Giovanni Brandi, Simona Tavolari, Francesco De Rosa, Stefania Di Girolamo, Valentina Agostini, Maria Aurelia Barbera, Giorgio Frega, Guido Biasco
Published 2012-01-01
Article -
5
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center by Alessandro Rizzo, Riccardo Carloni, Giorgio Frega, Andrea Palloni, Alessandro Di Federico, Angela Dalia Ricci, Raffaele De Luca, Simona Tavolari, Giovanni Brandi
Published 2022-07-01
Article -
6
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures by Alessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, Giorgio Frega, Andrea Palloni, Valeria Relli, Massimiliano Salati, Elisabetta Fenocchio, Annamaria Massa, Massimo Aglietta, Giovanni Brandi
Published 2020-11-01
Article -
7
Hacking Pancreatic Cancer: Present and Future of Personalized Medicine by Alessandro Di Federico, Valentina Tateo, Claudia Parisi, Francesca Formica, Riccardo Carloni, Giorgio Frega, Alessandro Rizzo, Dalia Ricci, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi
Published 2021-07-01
Article -
8
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study by Francesco Vasuri, Marzia Deserti, Angelo G. Corradini, Simona Tavolari, Valeria Relli, Andrea Palloni, Giorgio Frega, Stefania Curti, Stefano Mattioli, Matteo Cescon, Antonia D’Errico, Giovanni Brandi
Published 2023-02-01
Article -
9
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes by Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi
Published 2022-05-01
Article -
10
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma by Andrea Palloni, Silvia Bisello, Ilaria Maggio, Maria Massucci, Andrea Galuppi, Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, Giambattista Siepe, Alessio Giuseppe Morganti, Giovanni Brandi, Giorgio Frega
Published 2023-05-01
Article -
11
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges by Alessandro Rizzo MD, Alessandro Di Federico MD, Angela Dalia Ricci MD, Giorgio Frega MD, Andrea Palloni MD, Rachele Pagani MD, Simona Tavolari MD, Mariacristina Di Marco MD, Giovanni Brandi MD
Published 2020-12-01
Article -
12
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience by Giovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall’Olio, Cristina Felicani, Giorgio Ercolani, Matteo Cescon, Giorgio Frega, Simona Tavolari, Andrea Palloni, Stefania De Lorenzo, Francesca Abbati, Veronica Mollica, Angela Dalia Ricci, Carla Serra
Published 2020-01-01
Article -
13
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report by Emanuela Palmerini, Giorgio Frega, Marco Gambarotti, Tommaso Frisoni, Marilena Cesari, Alberto Bazzocchi, Marco Miceli, Davide Maria Donati, Davide Maria Donati, Stefano Fanti, Cristina Nanni, Stefania Benini, Alessandra Longhi, Anna Paioli, Andrea Marrari, Rossella Hakim, Alberto Righi, Toni Ibrahim
Published 2023-10-01
Article -
14
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study by Alessandro Rizzo, Massimiliano Salati, Giorgio Frega, Valeria Merz, Francesco Caputo, Alessandro Di Federico, Andrea Palloni, Riccardo Carloni, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, Carlo Messina, Andrea Spallanzani, Fabio Gelsomino, Stefania Benatti, Gabriele Luppi, Davide Melisi, Massimo Dominici, Giovanni Brandi
Published 2022-10-01
Article -
15
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study by Emanuela Palmerini, Laura Pazzaglia, Luca Cevolani, Loredana Pratelli, Michela Pierini, Irene Quattrini, Elisa Carretta, Maria Cristina Manara, Michela Pasello, Giorgio Frega, Anna Paioli, Alessandra Longhi, Marilena Cesari, Rossella Hakim, Toni Ibrahim, Laura Campanacci, Eric Lodewijk Staals, Davide Maria Donati, Maria Serena Benassi, Katia Scotlandi, Stefano Ferrari
Published 2022-06-01
Article